Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Stratification of Follicular Lymphoma: Time for a Paradigm Shift?

Kroft SH.

Am J Clin Pathol. 2019 May 3;151(6):539-541. doi: 10.1093/ajcp/aqz008. No abstract available.

PMID:
30918966
2.

Carcinocythemia: A rare entity becoming more common? A 3-year, single institution series of seven cases and literature review.

Ronen S, Kroft SH, Olteanu H, Hosking PR, Harrington AM.

Int J Lab Hematol. 2019 Feb;41(1):69-79. doi: 10.1111/ijlh.12924. Epub 2018 Sep 14.

PMID:
30216684
3.

The Evolution of the Clinical Pathologist.

Kroft SH.

Am J Clin Pathol. 2018 Aug 24. doi: 10.1093/ajcp/aqy119. [Epub ahead of print] No abstract available.

PMID:
30165557
4.

Flow Cytometry of B-Cell Neoplasms.

Kroft SH, Harrington AM.

Clin Lab Med. 2017 Dec;37(4):697-723. doi: 10.1016/j.cll.2017.07.001. Epub 2017 Aug 31. Review.

PMID:
29128065
5.

CD30 Expression in Monomorphic Posttransplant Lymphoproliferative Disorder, Diffuse Large B-Cell Lymphoma Correlates With Greater Regulatory T-Cell Infiltration.

Hartley C, Vaughan JW, Jarzembowski J, Kroft SH, Hosking P, Harrington AM, Olteanu H.

Am J Clin Pathol. 2017 Nov 20;148(6):485-493. doi: 10.1093/ajcp/aqx097.

PMID:
29126177
6.

Evaluation of CD43 expression in non-hematopoietic malignancies.

Batdorf BH, Kroft SH, Hosking PR, Harrington AM, Mackinnon AC, Olteanu H.

Ann Diagn Pathol. 2017 Aug;29:23-27. doi: 10.1016/j.anndiagpath.2017.04.010. Epub 2017 Apr 26.

PMID:
28807337
7.

Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic analysis.

Chang JC, Harrington AM, Olteanu H, VanTuinen P, Kroft SH.

Ann Diagn Pathol. 2016 Dec;25:15-19. doi: 10.1016/j.anndiagpath.2016.07.011. Epub 2016 Aug 18.

PMID:
27806839
8.

Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry:  A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes.

Harrington AM, Schelling LA, Ordobazari A, Olteanu H, Hosking PR, Kroft SH.

Am J Clin Pathol. 2016 Aug;146(2):170-81. doi: 10.1093/ajcp/aqw084. Epub 2016 Jul 13.

PMID:
27413139
9.

Rosai-Dorfman disease: Familiar yet enigmatic.

Kroft SH.

Semin Diagn Pathol. 2016 Sep;33(5):244-53. doi: 10.1053/j.semdp.2016.05.008. Epub 2016 May 20. Review. No abstract available.

PMID:
27370529
10.

Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms.

Li H, Hasserjian RP, Kroft SH, Harrington AM, Wheaton SE, Pildain A, Ewalt MD, Gratzinger D, Hosking P, Olteanu H.

Am J Clin Pathol. 2016 Apr;145(4):538-51. doi: 10.1093/ajcp/aqw033. Epub 2016 Apr 22.

PMID:
27124944
11.

Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates.

Cogbill CH, Spears MD, Vantuinen P, Harrington AM, Olteanu H, Kroft SH.

Int J Lab Hematol. 2015 Dec;37(6):797-808. doi: 10.1111/ijlh.12411. Epub 2015 Jul 30.

PMID:
26224420
12.

Teamwork key to reducing lab-results errors.

Kroft SH.

Mod Healthc. 2014 May 19;44(20):25. No abstract available.

PMID:
25055465
13.

Retraction: DNA methylation profiles of lymphoid and hematopoietic malignancies.

Takahashi T, Shivapurkar N, Reddy J, Shigematsu H, Miyajima K, Suzuki M, Toyooka S, Zöchbauer-Müller S, Drach J, Parikh G, Zheng Y, Feng Z, Kroft SH, Timmons C, McKenna RW, Gazdar AF.

Clin Cancer Res. 2013 Jan 1;19(1):307. doi: 10.1158/1078-0432.CCR-12-3679. Epub 2012 Dec 17. No abstract available.

14.

CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma.

Olteanu H, Harrington AM, Kroft SH.

Am J Clin Pathol. 2012 Dec;138(6):867-76. doi: 10.1309/AJCP3TQR1TFHHGAS.

PMID:
23161721
15.

Time and temperature stability of T-cell subsets evaluated by a dual-platform method.

Olteanu H, Schur BC, Harrington AM, Kroft SH.

Am J Blood Res. 2012;2(2):128-35. Epub 2012 May 25.

16.

Immunophenotypic stability of CD200 expression in plasma cell myeloma.

Olteanu H, Harrington AM, Kroft SH.

Am J Clin Pathol. 2012 Jun;137(6):1013-4. doi: 10.1309/AJCP8TF3WUIWLZHU. No abstract available.

PMID:
22586062
17.

A dissection of the CD45/side scatter "blast gate".

Harrington AM, Olteanu H, Kroft SH.

Am J Clin Pathol. 2012 May;137(5):800-4. doi: 10.1309/AJCPN4G1IZPABRLH.

PMID:
22523220
18.

Immunophenotypic stability of Sézary cells by flow cytometry: usefulness of flow cytometry in assessing response to and guiding alemtuzumab therapy.

Vaughan J, Harrington AM, Hari PN, Kroft SH, Olteanu H.

Am J Clin Pathol. 2012 Mar;137(3):403-11. doi: 10.1309/AJCP7QHH5XASTJPL.

PMID:
22338052
19.

Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases.

Bieliauskas S, Tubbs RR, Bacon CM, Eshoa C, Foucar K, Gibson SE, Kroft SH, Sohani AR, Swerdlow SH, Cook JR.

Am J Surg Pathol. 2012 Apr;36(4):534-43. doi: 10.1097/PAS.0b013e318240590a.

20.

Flow cytometric analysis of surface light chain expression patterns in B-cell lymphomas using monoclonal and polyclonal antibodies.

Horna P, Olteanu H, Kroft SH, Harrington AM.

Am J Clin Pathol. 2011 Dec;136(6):954-9. doi: 10.1309/AJCP3C2QZZBPTMLB.

PMID:
22095382
21.

Clinicopathologic analysis of the impact of CD23 expression in plasma cell myeloma with t(11;14)(q13;q32).

Buonaccorsi JN, Kroft SH, Harrington AM, VanTuinen P, Olteanu H.

Ann Diagn Pathol. 2011 Dec;15(6):385-8. doi: 10.1016/j.anndiagpath.2011.04.004. Epub 2011 Jul 2.

PMID:
21724429
22.

High prevalence of Dapsone-induced oxidant hemolysis in North American SCT recipients without glucose-6-phosphate-dehydrogenase deficiency.

Olteanu H, Harrington AM, George B, Hari PN, Bredeson C, Kroft SH.

Bone Marrow Transplant. 2012 Mar;47(3):399-403. doi: 10.1038/bmt.2011.83. Epub 2011 Apr 11.

PMID:
21478917
23.

The immunophenotypic stability of plasma cell myeloma by flow cytometry.

Spears MD, Olteanu H, Kroft SH, Harrington AM.

Int J Lab Hematol. 2011 Oct;33(5):483-91. doi: 10.1111/j.1751-553X.2011.01317.x. Epub 2011 Apr 7.

PMID:
21470371
24.

Immunophenotypic signatures of benign and dysplastic granulopoiesis by cytomic profiling.

Finn WG, Harrington AM, Carter KM, Raich R, Kroft SH, Hero AO 3rd.

Cytometry B Clin Cytom. 2011 Sep;80(5):282-90. doi: 10.1002/cyto.b.20592. Epub 2011 Apr 1.

25.

The unique immunophenotype of double-hit lymphomas.

Harrington AM, Olteanu H, Kroft SH, Eshoa C.

Am J Clin Pathol. 2011 Apr;135(4):649-50. doi: 10.1309/AJCPL11MAHISIJBQ. No abstract available.

PMID:
21411790
26.

A mysterious malady: the Malachowski-Wright-Giemsa stain to the rescue.

Ward PC, Glassy EF, Kroft SH, Krafts KP.

Biotech Histochem. 2011 Apr;86(2):76-81. doi: 10.3109/10520295.2010.515495.

PMID:
21395492
27.

CD200 expression in plasma cell myeloma.

Olteanu H, Harrington AM, Hari P, Kroft SH.

Br J Haematol. 2011 May;153(3):408-11. doi: 10.1111/j.1365-2141.2010.08555.x. Epub 2011 Jan 31. No abstract available.

PMID:
21275968
28.

CD23 expression in follicular lymphoma: clinicopathologic correlations.

Olteanu H, Fenske TS, Harrington AM, Szabo A, He P, Kroft SH.

Am J Clin Pathol. 2011 Jan;135(1):46-53. doi: 10.1309/AJCP27YWLIQRAJPW.

PMID:
21173123
29.

Immunophenotypic stability of T-cell large granular lymphocytic leukaemia by flow cytometry.

Spears MD, Harrington AM, Kroft SH, Olteanu H.

Br J Haematol. 2010 Oct;151(1):97-9. doi: 10.1111/j.1365-2141.2010.08307.x. Epub 2010 Jul 16. No abstract available.

PMID:
20636433
30.

Persistent localized bone marrow aplasia after radiotherapy with preserved peripheral counts: a study of 8 cases.

Harrington AM, Currey A, Olteanu H, Kroft SH.

Ann Diagn Pathol. 2010 Jun;14(3):168-72. doi: 10.1016/j.anndiagpath.2010.02.006.

PMID:
20471561
31.

Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia.

Olteanu H, Harrington AM, Ramirez S, Kroft SH, Hari P.

Br J Haematol. 2010 Aug;150(4):480-1. doi: 10.1111/j.1365-2141.2010.08218.x. Epub 2010 Apr 28. No abstract available.

PMID:
20456357
32.

Expression of natural killer receptors in T- and NK-cells: comparison of healthy individuals, patients with prior stem cell transplant, and patients undergoing chemotherapy.

Olteanu H, Schur BC, Bredeson C, Atallah E, Kroft SH.

Leuk Lymphoma. 2010 Mar;51(3):481-7. doi: 10.3109/10428190903552120. Epub 2010 Feb 8.

PMID:
20141431
33.

Laboratory findings in CD4(+) large granular lymphocytoses.

Olteanu H, Karandikar NJ, Eshoa C, Kroft SH.

Int J Lab Hematol. 2010 Feb;32(1 Pt 1):e9-16. doi: 10.1111/j.1751-553X.2008.01109.x. Epub 2008 Oct 8.

PMID:
20089001
34.

CD23 expression in plasma cell myeloma is specific for abnormalities of chromosome 11, and is associated with primary plasma cell leukaemia in this cytogenetic sub-group.

Walters M, Olteanu H, Van Tuinen P, Kroft SH.

Br J Haematol. 2010 Apr;149(2):292-3. doi: 10.1111/j.1365-2141.2009.08042.x. Epub 2010 Jan 8. No abstract available.

PMID:
20064156
35.

Sperm in peritoneal fluid from a man with ascites: a case report.

Olteanu H, Harrington A, Kroft SH.

Cases J. 2009 Nov 12;2:192. doi: 10.1186/1757-1626-2-192.

36.

Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia.

Seegmiller AC, Kroft SH, Karandikar NJ, McKenna RW.

Am J Clin Pathol. 2009 Dec;132(6):940-9. doi: 10.1309/AJCP8G5RMTWUEMUU.

PMID:
19926587
37.

Utility of CD56 immunohistochemical studies in follow-up of plasma cell myeloma.

Harrington AM, Hari P, Kroft SH.

Am J Clin Pathol. 2009 Jul;132(1):60-6. doi: 10.1309/AJCPOP7TQ3VHHKPC.

PMID:
19864234
38.

Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia.

Pullarkat ST, Pullarkat V, Kroft SH, Wilson CS, Ahsanuddin AN, Mann KP, Thein M, Grody WW, Brynes RK.

J Hematop. 2009 Mar;2(1):27-33. doi: 10.1007/s12308-009-0023-2. Epub 2009 Feb 10.

39.

Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors.

Nand R, Bryke C, Kroft SH, Divgi A, Bredeson C, Atallah E.

Leuk Res. 2009 Aug;33(8):1144-6. doi: 10.1016/j.leukres.2009.03.011. Epub 2009 Apr 25.

PMID:
19394693
40.

Overexpression of CD7 in classical Hodgkin lymphoma-infiltrating T lymphocytes.

Seegmiller AC, Karandikar NJ, Kroft SH, McKenna RW, Xu Y.

Cytometry B Clin Cytom. 2009 May;76(3):169-74. doi: 10.1002/cyto.b.20459.

41.

Pencil cells and prekeratocytes in iron deficiency anemia.

Harrington AM, Kroft SH.

Am J Hematol. 2008 Dec;83(12):927. doi: 10.1002/ajh.21283. No abstract available.

42.

Treatment of diffuse large B-cell lymphoma of the liver with yttrium-90 microsphere embolization.

Fenske TS, Benjamin H, Kroft SH, Hohenwalter EJ, Rilling WS.

Nat Clin Pract Oncol. 2008 Nov;5(11):677-81. doi: 10.1038/ncponc1227. Epub 2008 Sep 16. Erratum in: Nat Clin Pract Oncol. 2008 Nov;5(11):681.

PMID:
18797436
43.

Uncovering clinically relevant phenotypic variations in malignancies: CD23 in mantle cell lymphoma.

Kroft SH.

Am J Clin Pathol. 2008 Aug;130(2):159-61. doi: 10.1309/FTEP3KEXW7T2UEXY. No abstract available.

PMID:
18628082
44.

Long-term remission with imatinib mesylate in Philadelphia chromosome-positive AML presenting as primary extramedullary myeloid sarcoma.

Ahmed MS, Kroft SH, Davis NB, King DM, Cheng YC.

Leuk Res. 2008 Sep;32(9):1476-9. doi: 10.1016/j.leukres.2008.01.012. Epub 2008 Mar 4.

PMID:
18308388
45.

Iron deficiency anemia, beta-thalassemia minor, and anemia of chronic disease: a morphologic reappraisal.

Harrington AM, Ward PC, Kroft SH.

Am J Clin Pathol. 2008 Mar;129(3):466-71. doi: 10.1309/LY7YLUPE7551JYBG.

PMID:
18285271
46.

Anaplastic large cell lymphoma: a flow cytometric analysis of 29 cases.

Kesler MV, Paranjape GS, Asplund SL, McKenna RW, Jamal S, Kroft SH.

Am J Clin Pathol. 2007 Aug;128(2):314-22.

PMID:
17638668
47.

White blood cell changes in hyperthermia.

Ward PC, McKenna RW, Kroft SH.

Br J Haematol. 2007 Jul;138(2):130. Epub 2007 Apr 30. No abstract available.

PMID:
17474971
49.

ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature.

Reichard KK, McKenna RW, Kroft SH.

Mod Pathol. 2007 Mar;20(3):310-9. Epub 2007 Feb 2.

50.

Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: a single institution experience.

Chen W, Karandikar NJ, McKenna RW, Kroft SH.

Am J Clin Pathol. 2007 Jan;127(1):39-46.

PMID:
17145625

Supplemental Content

Loading ...
Support Center